{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:58:34Z","timestamp":1784746714530,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12013-024-01217-9","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T02:01:51Z","timestamp":1705716111000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth"],"prefix":"10.1007","volume":"82","author":[{"given":"Mai Ly Thi","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Tran","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong Linh Thi","family":"Nham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ba Thang","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Tuan","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc Vuong","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan Cuong","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw","family":"Bozko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linh Toan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-5898","authenticated-orcid":false,"given":"Khac Cuong","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"key":"1217_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A. & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1217_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D. & Bray, F. (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"International Journal of Cancer"},{"key":"1217_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countrie.CA: A Cancer Journal for Clinicians, 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1217_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J. & Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1217_CR5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A.(2019). Hepatocellular carcinoma. New England Journal of Medicine, 380, 1450\u20131462. https:\/\/doi.org\/10.1056\/NEJMra1713263.","journal-title":"New England Journal of Medicine"},{"key":"1217_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/jgo.2016.09.07","volume":"8","author":"DW Kim","year":"2017","unstructured":"Kim, D. W., Talati, C. & Kim, R. (2017). Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy. Journal of Gastrointestinal Oncology, 8, 256\u2013265. https:\/\/doi.org\/10.21037\/jgo.2016.09.07.","journal-title":"Journal of Gastrointestinal Oncology"},{"key":"1217_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/hep.27443","volume":"61","author":"EG Giannini","year":"2015","unstructured":"Giannini, E. G., Farinati, F., Ciccarese, F., Pecorelli, A., Rapaccini, G. L., Di Marco, M., Benvegn\u00f9, L., Caturelli, E., Zoli, M., Borzio, F., Chiaramonte, M., & Trevisani, F. (2015). Prognosis of untreated hepatocellular carcinoma. Hepatology, 61, 184\u2013190. https:\/\/doi.org\/10.1002\/hep.27443.","journal-title":"Hepatology"},{"key":"1217_CR8","doi-asserted-by":"publisher","first-page":"88537","DOI":"10.18632\/oncotarget.19877","volume":"8","author":"S Fu","year":"2017","unstructured":"Fu, S., Xu, H., Gu, M., Liu, C., Wan, X., Chen, Y., Chen, Q., Zhou, J., & Wang, Z. (2017). Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia. Oncotarget, 8, 88537\u201388551. https:\/\/doi.org\/10.18632\/oncotarget.19877.","journal-title":"Oncotarget"},{"key":"1217_CR9","doi-asserted-by":"publisher","unstructured":"Nehme, R., Diab-Assaf, M., Decombat, C., Delort, L., & Caldefie-Chezet, F. (2022). Targeting adiponectin in breast cancer. Biomedicines 10. https:\/\/doi.org\/10.3390\/biomedicines10112958.","DOI":"10.3390\/biomedicines10112958"},{"key":"1217_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., & Kadowaki, T. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762\u2013769. https:\/\/doi.org\/10.1038\/nature01705.","journal-title":"Nature"},{"key":"1217_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1210\/er.2011-1015","volume":"33","author":"M Dalamaga","year":"2012","unstructured":"Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012). The role of adiponectin in cancer: a review of current evidence. Endocrine Reviews, 33, 547\u2013594. https:\/\/doi.org\/10.1210\/er.2011-1015.","journal-title":"Endocrine Reviews"},{"key":"1217_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jhep.2007.03.020","volume":"47","author":"Y Kamada","year":"2007","unstructured":"Kamada, Y., Matsumoto, H., Tamura, S., Fukushima, J., Kiso, S., Fukui, K., Igura, T., Maeda, N., Kihara, S., Funahashi, T., Matsuzawa, Y., Shimomura, I. & Hayashi, N. (2007). Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. Journal of Hepatology, 47, 556\u2013564. https:\/\/doi.org\/10.1016\/j.jhep.2007.03.020.","journal-title":"Journal of Hepatology"},{"key":"1217_CR13","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1136\/gut.2008.159293","volume":"57","author":"T Fujisawa","year":"2008","unstructured":"Fujisawa, T., Endo, H., Tomimoto, A., Sugiyama, M., Takahashi, H., Saito, S., Inamori, M., Nakajima, N., Watanabe, M., Kubota, N., Yamauchi, T., Kadowaki, T., Wada, K., Nakagama, H., & Nakajima, A. (2008). Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut, 57, 1531\u20131538. https:\/\/doi.org\/10.1136\/gut.2008.159293.","journal-title":"Gut"},{"key":"1217_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.biocel.2013.03.003","volume":"45","author":"E Nigro","year":"2013","unstructured":"Nigro, E., Scudiero, O., Sarnataro, D., Mazzarella, G., Sofia, M., Bianco, A. & Daniele, A. (2013). Adiponectin affects lung epithelial A549 cell viability counteracting TNFalpha and IL-1ss toxicity through AdipoR1. International Journal of Biochemistry & Cell Biology, 45, 1145\u20131153. https:\/\/doi.org\/10.1016\/j.biocel.2013.03.003.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"1217_CR15","doi-asserted-by":"publisher","unstructured":"Gamberi, T., Magherini, F., Modesti, A. & Fiaschi, T. (2018) Adiponectin signaling pathways in liver diseases. Biomedicines 6. https:\/\/doi.org\/10.3390\/biomedicines6020052.","DOI":"10.3390\/biomedicines6020052"},{"key":"1217_CR16","doi-asserted-by":"publisher","unstructured":"Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., & Matsuzawa, Y. (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96, 1723\u20131732. https:\/\/doi.org\/10.1182\/blood.V96.5.1723.","DOI":"10.1182\/blood.V96.5.1723"},{"key":"1217_CR17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/sj.bjc.6603051","volume":"94","author":"I Kelesidis","year":"2006","unstructured":"Kelesidis, I., Kelesidis, T. & Mantzoros, C. S. (2006). Adiponectin and cancer: a systematic review. British Journal of Cancer, 94, 1221\u20131225. https:\/\/doi.org\/10.1038\/sj.bjc.6603051.","journal-title":"British Journal of Cancer"},{"key":"1217_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.RES.0000163633.10240.3b","volume":"96","author":"N Ouchi","year":"2005","unstructured":"Ouchi, N., Shibata, R. & Walsh, K. (2005). AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circulation Research, 96, 838\u2013846. https:\/\/doi.org\/10.1161\/01.RES.0000163633.10240.3b.","journal-title":"Circulation Research"},{"key":"1217_CR19","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2010.07.001","volume":"139","author":"NK Saxena","year":"2010","unstructured":"Saxena, N. K., Fu, P. P., Nagalingam, A., Wang, J., Handy, J., Cohen, C., Tighiouart, M., Sharma, D., & Anania, F. A. (2010). Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology, 139, 1762\u20131773. https:\/\/doi.org\/10.1053\/j.gastro.2010.07.001.","journal-title":"Gastroenterology"},{"key":"1217_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., Ogata, H., Tokuyama, K., Ueki, K., Nagano, T., Tanaka, A., Yokoyama, S., & Kadowaki, T. (2013). A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature, 503, 493\u2013499. https:\/\/doi.org\/10.1038\/nature12656.","journal-title":"Nature"},{"key":"1217_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0851-z","volume":"9","author":"M Akimoto","year":"2018","unstructured":"Akimoto, M., Maruyama, R., Kawabata, Y., Tajima, Y., & Takenaga, K. (2018). Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1\/ERK-dependent necroptosis. Cell Death & Disease, 9, 804 https:\/\/doi.org\/10.1038\/s41419-018-0851-z.","journal-title":"Cell Death & Disease"},{"key":"1217_CR22","doi-asserted-by":"publisher","first-page":"837503","DOI":"10.3389\/fphar.2022.837503","volume":"13","author":"A Ragone","year":"2022","unstructured":"Ragone, A., Salzillo, A., Spina, A., Naviglio, S. & Sapio, L. (2022). Integrating gemcitabine-based therapy with adiporon enhances growth inhibition in human PDAC cell lines. Frontiers in Pharmacology, 13, 837503. https:\/\/doi.org\/10.3389\/fphar.2022.837503.","journal-title":"Frontiers in Pharmacology"},{"key":"1217_CR23","doi-asserted-by":"publisher","unstructured":"Zhang, Z., Du, J., Xu, Q., Xing, C., Li, Y., Zhou, S., Zhao, Z., Mu, Y., Zhao, Z. A., Cao, S., & Li, F. (2022) Adiponectin suppresses metastasis of nasopharyngeal carcinoma through blocking the activation of NF-kappaB and STAT3 signaling. International Journal of Molecular Sciences 23. https:\/\/doi.org\/10.3390\/ijms232112729.","DOI":"10.3390\/ijms232112729"},{"key":"1217_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03283-0","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., Du, J., Shi, H., Wang, S., Yan, Y., Xu, Q., Zhou, S., Zhao, Z., Mu, Y., Qian, C., Zhao, A. Z., Cao, S. & Li, F. (2022). Adiponectin suppresses tumor growth of nasopharyngeal carcinoma through activating AMPK signaling pathway. Journal of Translational Medicine, 20, 89. https:\/\/doi.org\/10.1186\/s12967-022-03283-0.","journal-title":"Journal of Translational Medicine"},{"key":"1217_CR25","doi-asserted-by":"publisher","first-page":"7262479","DOI":"10.1155\/2020\/7262479","volume":"2020","author":"L Sapio","year":"2020","unstructured":"Sapio, L., Nigro, E., Ragone, A., Salzillo, A., Illiano, M., Spina, A., Polito, R., Daniele, A., & Naviglio, S. (2020). AdipoRon affects cell cycle progression and inhibits proliferation in human osteosarcoma cells. Journal of Clinical Oncology, 2020, 7262479 https:\/\/doi.org\/10.1155\/2020\/7262479.","journal-title":"Journal of Clinical Oncology"},{"key":"1217_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.19746\/j.cnki.issn.1009-2137.2020.01.029","volume":"28","author":"SJ Wang","year":"2020","unstructured":"Wang, S. J., Wang, C., Wang, W. Q., Hao, Q. Q., & Liu, Y. F. (2020). [Adiponectin receptor agonist adiporon inhibits the proliferation of myeloma cells via the AMPK\/Autophagy pathway]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 28, 171\u2013176. https:\/\/doi.org\/10.19746\/j.cnki.issn.1009-2137.2020.01.029.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"1217_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11010-019-03586-9","volume":"461","author":"AA Ramzan","year":"2019","unstructured":"Ramzan, A. A., Bitler, B. G., Hicks, D., Barner, K., Qamar, L., Behbakht, K., Powell, T., Jansson, T., & Wilson, H. (2019). Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells. Molecular and Cellular Biochemistry, 461, 37\u201346. https:\/\/doi.org\/10.1007\/s11010-019-03586-9.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"1217_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fphys.2014.00017","volume":"5","author":"R Garcia-Areas","year":"2014","unstructured":"Garcia-Areas, R., Libreros, S., Amat, S., Keating, P., Carrio, R., Robinson, P., Blieden, C., & Iragavarapu-Charyulu, V. (2014). Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice. Frontiers in Physiology, 5, 17 https:\/\/doi.org\/10.3389\/fphys.2014.00017.","journal-title":"Frontiers in Physiology"},{"key":"1217_CR29","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s12094-022-02889-6","volume":"24","author":"V Mehta","year":"2022","unstructured":"Mehta, V., Suman, P., & Chander, H. (2022). High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues. Clinical and Translational Oncology, 24, 2351\u20132365. https:\/\/doi.org\/10.1007\/s12094-022-02889-6.","journal-title":"Clinical and Translational Oncology"},{"key":"1217_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/jcmm.17171","volume":"26","author":"R Xiao","year":"2022","unstructured":"Xiao, R., Wang, S., Guo, J., Liu, S., Ding, A., Wang, G., Li, W., Zhang, Y., Bian, X., Zhao, S., & Qiu, W. (2022). Ferroptosis-related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma. Journal of Cellular and Molecular Medicine, 26, 1183\u20131193. https:\/\/doi.org\/10.1111\/jcmm.17171.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1217_CR31","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1172\/JCI29126","volume":"116","author":"T Kadowaki","year":"2006","unstructured":"Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., & Tobe, K. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation, 116, 1784\u20131792. https:\/\/doi.org\/10.1172\/JCI29126.","journal-title":"Journal of Clinical Investigation"},{"key":"1217_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki, T., & Yamauchi, T. (2005). Adiponectin and adiponectin receptors. Endocrine Reviews, 26, 439\u2013451. https:\/\/doi.org\/10.1210\/er.2005-0005.","journal-title":"Endocrine Reviews"},{"key":"1217_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nm1557","volume":"13","author":"T Yamauchi","year":"2007","unstructured":"Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., Ito, Y., Kamon, J., Tsuchida, A., Kumagai, K., Kozono, H., Hada, Y., Ogata, H., Tokuyama, K., Tsunoda, M., Ide, T., Murakami, K., Awazawa, M., Takamoto, I., Froguel, P., Hara, K., Tobe, K., Nagai, R., Ueki, K., & Kadowaki, T. (2007). Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Medicine, 13, 332\u2013339. https:\/\/doi.org\/10.1038\/nm1557.","journal-title":"Nature Medicine"},{"key":"1217_CR34","doi-asserted-by":"publisher","unstructured":"Parida, S., Siddharth, S., & Sharma, D. (2019) Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. International Journal of Molecular Sciences 20. https:\/\/doi.org\/10.3390\/ijms20102519.","DOI":"10.3390\/ijms20102519"},{"key":"1217_CR35","doi-asserted-by":"publisher","unstructured":"Nigro, E., Daniele, A., Salzillo, A., Ragone, A., Naviglio, S., & Sapio, L. (2021) AdipoRon and other adiponectin receptor agonists as potential candidates in cancer treatments. International Journal of Molecular Sciences 22. https:\/\/doi.org\/10.3390\/ijms22115569.","DOI":"10.3390\/ijms22115569"},{"key":"1217_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13046-021-02223-y","volume":"41","author":"DV Pham","year":"2022","unstructured":"Pham, D. V., & Park, P. H. (2022). Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming. Journal of Experimental & Clinical Cancer Research, 41, 9 https:\/\/doi.org\/10.1186\/s13046-021-02223-y.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"1217_CR37","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/ol.2015.3965","volume":"11","author":"E Falk Libby","year":"2016","unstructured":"Falk Libby, E., Liu, J., Li, Y. I., Lewis, M. J., Demark-Wahnefried, W., & Hurst, D. R. (2016). Globular adiponectin enhances invasion in human breast cancer cells. Oncology Letters, 11, 633\u2013641. https:\/\/doi.org\/10.3892\/ol.2015.3965.","journal-title":"Oncology Letters"},{"key":"1217_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12013-014-9941-4","volume":"70","author":"Q Gao","year":"2014","unstructured":"Gao, Q., & Zheng, J. (2014). Adiponectin-induced antitumor activity on prostatic cancers through inhibiting proliferation. Cell Biochemistry and Biophysics, 70, 461\u2013465. https:\/\/doi.org\/10.1007\/s12013-014-9941-4.","journal-title":"Cell Biochemistry and Biophysics"},{"key":"1217_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-007-9874-3","volume":"112","author":"S Nakayama","year":"2008","unstructured":"Nakayama, S., Miyoshi, Y., Ishihara, H., & Noguchi, S. (2008). Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Research and Treatment, 112, 405\u2013410. https:\/\/doi.org\/10.1007\/s10549-007-9874-3.","journal-title":"Breast Cancer Research and Treatment"},{"key":"1217_CR40","doi-asserted-by":"publisher","unstructured":"Abdul-Ghafar, J., Oh, S. S., Park, S. M., Wairagu, P., Lee, S. N., Jeong, Y., Eom, M., Yong, S. J., & Jung, S. H. (2013). Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma. Tohoku Journal of Experimental Medicine, 229, 153\u2013162. https:\/\/doi.org\/10.1620\/tjem.229.153.","DOI":"10.1620\/tjem.229.153"},{"key":"1217_CR41","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1165\/rcmb.2011-0068OC","volume":"46","author":"K Niu","year":"2012","unstructured":"Niu, K., Asada, M., Okazaki, T., Yamanda, S., Ebihara, T., Guo, H., Zhang, D., Nagatomi, R., Arai, H., Kohzuki, M., & Ebihara, S. (2012). Adiponectin pathway attenuates malignant mesothelioma cell growth. American Journal of Respiratory Cell and Molecular Biology, 46, 515\u2013523. https:\/\/doi.org\/10.1165\/rcmb.2011-0068OC.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"1217_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41419-022-04572-8","volume":"13","author":"SJ Manley","year":"2022","unstructured":"Manley, S. J., Olou, A. A., Jack, J. L., Ruckert, M. T., Walsh, R. M., Eades, A. E., Bye, B. A., Ambrose, J., Messaggio, F., Anant, S., & VanSaun, M. N. (2022). Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. Cell Death & Disease, 13, 114 https:\/\/doi.org\/10.1038\/s41419-022-04572-8.","journal-title":"Cell Death & Disease"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01217-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:14:09Z","timestamp":1724480049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01217-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01217-9","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}